Therapy for relapsed multiple myeloma

Mohammed A. Aljama, M. Hasib Sidiqi, David M Dingli

Research output: Contribution to journalReview article

Abstract

Despite significant progress in our understanding and the development of novel therapies, most patients with multiple myeloma will experience relapse of their disease. Therapy of relapsed myeloma has improved due to the availability of novel agents that are highly active against the disease. However, the selection of therapy can be challenging due to the emergence of toxicities, comorbidities and frailty. In the following we discuss our approach to the treatment of the patient with relapsed myeloma.

Original languageEnglish (US)
Pages (from-to)174-184
Number of pages11
JournalPanminerva Medica
Volume60
Issue number4
DOIs
StatePublished - Dec 1 2018

    Fingerprint

Keywords

  • Multiple myeloma
  • Recurrence
  • Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this